Ethypharm is a specialty pharmaceutical company with European roots, dedicated to addressing specific Central Nervous System (CNS) diseases and conditions, as well as Hospital Injectables. Their commitment lies in providing the right treatment and support to patients suffering from debilitating conditions such as chronic pain or addiction, ensuring they receive the necessary care at the right time.
With a focus on CNS and Hospital Injectables, Ethypharm strives to add value by treating patients today and working on innovative solutions for tomorrow. As a rapidly transforming company, they have a clear strategy and ambitious growth plans, constantly seeking opportunities to expand their product portfolio, enhance geographical coverage, and enrich their development pipeline.
Generated from the website
